Pharmacokinetic Services

Clinipace Worldwide provides extensive pharmacokinetic (PK) and pharmacodynamic (PD) support - as part of our Biostatistics services - in Phase 1-3 clinical studies in accordance with international regulatory standards (FDA, EMEA, and ICH).

Clinipace offers human pharmacology services that include, but are not limited to, single- and multiple-dose pharmacokinetic (PK) studies, bioavailability studies, bioequivalence studies, drug-drug interaction studies (DDI), population PK, and PK/PD or dose-response studies. Additionally, we provide the following services to our biopharmaceutical clients:

  • Pharmacokinetic study design
  • Consulting and liaison with regulatory agency officials
  • Pharmacokinetic protocol authorship
  • Pharmacokinetic data analysis and modeling
  • Pharmacokinetic clinical study report writing